BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

860 related articles for article (PubMed ID: 19167590)

  • 1. Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema.
    Birjmohun RS; Kees Hovingh G; Stroes ES; Hofstra JJ; Dallinga-Thie GM; Meijers JC; Kastelein JJ; Levi M
    Clin Ther; 2008 Dec; 30(12):2314-23. PubMed ID: 19167590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema.
    Széplaki G; Varga L; Valentin S; Kleiber M; Karádi I; Romics L; Füst G; Farkas H
    J Allergy Clin Immunol; 2005 Apr; 115(4):864-9. PubMed ID: 15806011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term danazol prophylaxis does not lead to increased carotid intima-media thickness in hereditary angioedema patients.
    Szegedi R; Széplaki G; Varga L; Prohászka Z; Széplaki Z; Karádi I; Füst G; Farkas H
    Atherosclerosis; 2008 May; 198(1):184-91. PubMed ID: 17977544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.
    Davidson M; Meyer PM; Haffner S; Feinstein S; D'Agostino R; Kondos GT; Perez A; Chen Z; Mazzone T
    Circulation; 2008 Apr; 117(16):2123-30. PubMed ID: 18413496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study.
    Juonala M; Viikari JS; Kähönen M; Solakivi T; Helenius H; Jula A; Marniemi J; Taittonen L; Laitinen T; Nikkari T; Raitakari OT
    J Am Coll Cardiol; 2008 Jul; 52(4):293-9. PubMed ID: 18634985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of L-thyroxine replacement therapy on carotid intima-media thickness in patients with primary hypothyroidism.
    Cakal E; Turgut AT; Demirbas B; Ozkaya M; Cakal B; Serter R; Aral Y
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):294-300. PubMed ID: 19085705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of dehydroepiandrosterone in type I and II hereditary angioedema and role of danazol in steroid hormone conversion.
    Thon V; Härle P; Schölmerich J; Kuklinek P; Lokaj J; Straub RH
    Allergy; 2007 Nov; 62(11):1320-5. PubMed ID: 17919148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesteryl ester transfer protein in metabolic syndrome.
    Sandhofer A; Kaser S; Ritsch A; Laimer M; Engl J; Paulweber B; Patsch JR; Ebenbichler CF
    Obesity (Silver Spring); 2006 May; 14(5):812-8. PubMed ID: 16855190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac mass and function, carotid artery intima media thickness, homocysteine and lipoprotein levels in children and adolescents with growth hormone deficiency.
    Szczepańiska Kostro J; Tołwińska J; Urban M; Gardziejczyk M; Głowińska B
    J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1405-13. PubMed ID: 15526719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients.
    Bork K; Bygum A; Hardt J
    Ann Allergy Asthma Immunol; 2008 Feb; 100(2):153-61. PubMed ID: 18320917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
    Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
    Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early onset of subclinical atherosclerosis in women with gestational diabetes mellitus.
    Tarim E; Yigit F; Kilicdag E; Bagis T; Demircan S; Simsek E; Haydardedeoglu B; Yanik F
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):177-82. PubMed ID: 16435313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of atorvastatin on serum lipoproteins in acromegaly.
    Mishra M; Durrington P; Mackness M; Siddals KW; Kaushal K; Davies R; Gibson M; Ray DW
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):650-5. PubMed ID: 15943824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis--a randomized study.
    Hafström I; Rohani M; Deneberg S; Wörnert M; Jogestrand T; Frostegård J
    J Rheumatol; 2007 Sep; 34(9):1810-6. PubMed ID: 17696277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone enanthate at a dose of 200 mg/week decreases HDL-cholesterol levels in healthy men.
    Meriggiola MC; Marcovina S; Paulsen CA; Bremner WJ
    Int J Androl; 1995 Oct; 18(5):237-42. PubMed ID: 8567093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proatherogenic disturbances in lipoprotein profile, associated enzymes and transfer proteins in women with iron deficiency anaemia.
    Meroño T; Sorroche P; Gómez Rosso LA; Casañas L; Boero LE; Arbelbide JA; Brites FD
    Clin Biochem; 2010 Mar; 43(4-5):416-23. PubMed ID: 19850020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipoproteins and cancer.
    Muntoni S; Atzori L; Mereu R; Satta G; Macis MD; Congia M; Tedde A; Desogus A; Muntoni S
    Nutr Metab Cardiovasc Dis; 2009 Mar; 19(3):218-25. PubMed ID: 18718745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compromised LCAT function is associated with increased atherosclerosis.
    Hovingh GK; Hutten BA; Holleboom AG; Petersen W; Rol P; Stalenhoef A; Zwinderman AH; de Groot E; Kastelein JJ; Kuivenhoven JA
    Circulation; 2005 Aug; 112(6):879-84. PubMed ID: 16061733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
    Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
    Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.